Skip to content

Is There Any Difference in Survival According to the Portal Thrombectomy Method in Patients with Hepatocellular Carcinoma?

Is There Any Difference in Survival According to the Portal Thrombectomy Method in Patients with Hepatocellular Carcinoma? - PVTT thrombectomy comparison

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000000995
Enrollment
50
Registered
2008-01-26
Start date
1995-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resactable hepatocellular carcinoma (HCC) with macroscopic portal venous thrombus (PVTT)

Interventions

None listed

Sponsors

Hepato-Biliary-Pancreatic Surgery Division, Tokyo University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who have HCC with PVTT macroscopically detected with preoperative imaging modalities.

Exclusion criteria

Exclusion criteria: The patients who failed to reap the curative operation.

Design outcomes

Primary

MeasureTime frame
overall survival and recurrence-free survival

Countries

Japan

Contacts

Public ContactYosuke Inoue

Tokyo University Hospital Hepato-Biliary-Pancreatic Surgery Division

sukeyaubj@yahoo.co.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026